Skip to content

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jul 24, 2026

Data as of Oct 16

▼ SELL$969K1,818 shares at $533.20Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
Watch UTHR
Traded
Jul 24, 2026
Disclosed
Jul 27, 2026
Filed
3 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jul 24, 2026TRADEDDISCLOSED
UTHRSimilar stocks (XLV — its sector index fund), rebased to UTHR's price on the disclosure day
UTHR since disclosure
+1.0%
after the sale
Similar stocks (XLV) since disclosure
+8.1%
XLV — its sector index fund

Change in closing price from Jul 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.4Mdisclosed Jul 27 · filed 3 days after the trade
  2. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$592Kdisclosed Jul 27 · filed 3 days after the trade
  3. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$60.5Kdisclosed Jul 27 · filed 3 days after the trade
  4. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$434Kdisclosed Jul 27 · filed 3 days after the trade
  5. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Jul 27 · filed 3 days after the trade
  6. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$337Kdisclosed Jul 27 · filed 3 days after the trade

See every trade on UTHR →